Tech Company Financing Transactions

Twentyeight-Seven Therapeutics Funding Round

On 9/7/2018, Twentyeight-Seven Therapeutics received $65 million in Series A investment from MPM Capital, Novartis Venture Fund and Astellas Venture Capital.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series A
Proceeds Purpose
The funding will be used to advance 28-7's lead program, aimed at the discovery and development of small molecules that increase the levels of the tumor suppressor microRNA (miRNA), Let-7, into serious cancer indications.

Company Information

Company Status
Private & Independent
Mailing Address
490 Arsenal Way 100B
Watertown, MA 02472
Email Address
Twentyeight-Seven Therapeutics is a focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases. By targeting ncRNA modulating proteins (RMPs), we can use small molecules to modulate expression levels of oncogenes and other proteins of significance in disease.
Twentyeight-Seven Therapeutics LinkedIn Company Profile
Social Media
Twentyeight-Seven Therapeutics Company Twitter Account
Company News
Twentyeight-Seven Therapeutics News
Twentyeight-Seven Therapeutics on Facebook
Twentyeight-Seven Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Kazumi Shiosaki
  Kazumi Shiosaki LinkedIn Profile  Kazumi Shiosaki Twitter Account  Kazumi Shiosaki News  Kazumi Shiosaki on Facebook
Chief Scientific Officer
Shomir Ghosh
  Shomir Ghosh LinkedIn Profile  Shomir Ghosh Twitter Account  Shomir Ghosh News  Shomir Ghosh on Facebook
VP - Bus. Development
Reid Leonard
  Reid Leonard LinkedIn Profile  Reid Leonard Twitter Account  Reid Leonard News  Reid Leonard on Facebook
VP - R & D
Ross Stein
  Ross Stein LinkedIn Profile  Ross Stein Twitter Account  Ross Stein News  Ross Stein on Facebook



Browse more venture capital transactions:

Prev: 9/7/2018: MIRROR venture capital transaction
Next: 9/7/2018: PagerDuty venture capital transaction


Share this article


About Our Venture Capital Transactions Database

We document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary